FDA Inspection 906173 — Prothya Biosolutions Netherlands B.V.

Prothya Biosolutions Netherlands B.V. — FEI 3007166802

The FDA completed an inspection of Prothya Biosolutions Netherlands B.V. on November 20, 2014 in Amsterdam. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 20, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Amsterdam (Netherlands)